Fahey M R, Miller R D
Contemp Anesth Pract. 1983;7:61-81.
There are many new neuromuscular blocking drugs now going through the clinical trials required before new drugs can be used clinically on a routine basis. It is safe to say that within the next five years the muscle relaxants now in common use will be replaced by new and more "ideal" muscle relaxants. This review has attempted to define for the practicing anesthesiologist the goals of muscle relaxant research and the drugs that have been developed from that research. It is hoped that some familiarity with these drugs before they become widely available may hasten their extensive use by practitioner in the interest of better anesthetic patient care.
目前有许多新型神经肌肉阻滞药物正在进行新药常规临床应用前所需的临床试验。可以肯定地说，在未来五年内，目前常用的肌肉松弛剂将被更新且更“理想”的肌肉松弛剂所取代。这篇综述试图为执业麻醉医师界定肌肉松弛剂研究的目标以及基于该研究开发出的药物。希望在这些药物广泛应用之前对其有所了解，可能会促使执业医师为了更好地进行麻醉患者护理而广泛使用它们。
